tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

OCUL Stock Latest News

Ocular Therapeutix added to Analyst Current Favorites list at Raymond James
The FlyOcular Therapeutix added to Analyst Current Favorites list at Raymond James
8d ago
OCUL
Ocular Therapeutix initiated with an Outperform at RBC Capital
PremiumThe Fly
Ocular Therapeutix initiated with an Outperform at RBC Capital
16d ago
OCUL
Beam, Unity, Checkpoint, Inuvo, Ocular: Trending by Analysts
PremiumWeekend Updates
Beam, Unity, Checkpoint, Inuvo, Ocular: Trending by Analysts
19d ago
U
BEAM
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
20d ago
ALDX
DWTX
Strategic Trial Adjustments and Efficiency Boost Ocular Therapeutix’s Prospects: A Buy Rating Justification
PremiumRatings
Strategic Trial Adjustments and Efficiency Boost Ocular Therapeutix’s Prospects: A Buy Rating Justification
21d ago
OCUL
Ocular Therapeutix initiated with a Buy at Needham
PremiumThe FlyOcular Therapeutix initiated with a Buy at Needham
23d ago
OCUL
Ocular Therapeutix: Strategic Developments and Revenue Growth Justify Buy Rating
Premium
Ratings
Ocular Therapeutix: Strategic Developments and Revenue Growth Justify Buy Rating
30d ago
OCUL
Ocular Therapeutix price target lowered to $19 at Citizens JMP, buy on weakness
Premium
The Fly
Ocular Therapeutix price target lowered to $19 at Citizens JMP, buy on weakness
30d ago
OCUL
Ocular Therapeutix Inc. Faces Operational Risks Amid Regulatory Delays and Government Disruptions
PremiumCompany Announcements
Ocular Therapeutix Inc. Faces Operational Risks Amid Regulatory Delays and Government Disruptions
1M ago
OCUL
Ocular Therapeutix Reports 2024 Financial Results and Progress
PremiumCompany Announcements
Ocular Therapeutix Reports 2024 Financial Results and Progress
1M ago
OCUL
Ocular Therapeutix Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
Ocular Therapeutix Earnings Call Highlights Progress and Challenges
1M ago
OCUL
Ocular Therapeutix: Strategic Amendments and Financial Strength Justify Buy Rating
PremiumRatings
Ocular Therapeutix: Strategic Amendments and Financial Strength Justify Buy Rating
1M ago
OCUL
Ocular Therapeutix reports Q4 EPS (29c), consensus (22c)
PremiumThe FlyOcular Therapeutix reports Q4 EPS (29c), consensus (22c)
1M ago
OCUL
Ocular Therapeutix sees cash runway into 2028
Premium
The Fly
Ocular Therapeutix sees cash runway into 2028
1M ago
OCUL
OCUL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
OCUL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
OCUL
Ocular Therapeutix Approves New CEO Compensation Package
PremiumCompany Announcements
Ocular Therapeutix Approves New CEO Compensation Package
2M ago
8K
OCUL
Ocular Therapeutix reports inducement grant under Nasdaq listing rule
PremiumThe Fly
Ocular Therapeutix reports inducement grant under Nasdaq listing rule
3M ago
OCUL
Ocular Therapeutix shares SOLR-R enrollment progress, next steps AXPAXLI
PremiumThe Fly
Ocular Therapeutix shares SOLR-R enrollment progress, next steps AXPAXLI
3M ago
OCUL
EyePoint initiated with a Buy at Citi
PremiumThe Fly
EyePoint initiated with a Buy at Citi
3M ago
EYPT
OCUL
Ocular Therapeutix reports inducement grant under Nasdaq listing rule
PremiumThe FlyOcular Therapeutix reports inducement grant under Nasdaq listing rule
4M ago
OCUL
Ocular Therapeutix announces over 300 subjects randomized in SOL-1
Premium
The Fly
Ocular Therapeutix announces over 300 subjects randomized in SOL-1
4M ago
OCUL
Ocular Therapeutix price target raised to $15 from $14 at H.C. Wainwright
Premium
The Fly
Ocular Therapeutix price target raised to $15 from $14 at H.C. Wainwright
5M ago
OCUL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >